A healthcare investing prediction: The world becomes fickle
Hey startup CEO: How will you need to think differently about protecting your assets in a way that allows you to build value in the long term?
Hey startup CEO: How will you need to think differently about protecting your assets in a way that allows you to build value in the long term?
There are plenty of good investors out there, but many will pull a Mr. Hyde act to get what they want from healthcare entrepreneurs.
It's time to know more about corporate venture capital because, unlike traditional venture or angel groups, there's much less insight on corporate VCs and their practices.
We all want the 12x, but what happens when you're the 1x - and how do you make sure nothing goes wrong?
Through litigation finance, CFOs can manage a dormant asset: potential litigation.
Last week, I discussed the changing landscape of medtech innovation, and how shifting dynamics in the capital raising process have led young businesses to be more vulnerable to unscrupulous partners and mal-intentioned competitors. This week I will begin discussing how distressed venture funding and litigation finance can be used to help protect these innovating young […]
Unfortunately, it is not uncommon for larger corporations to invest in promising healthcare companies, only to take advantage of their position by developing the underlying technology themselves or dispensing with the project so as to avoid cannibalizing sales.
Distressed venture finance and litigation finance are relatively new financial products that can help otherwise vulnerable businesses protect themselves. Companies, such as Lake Whillans, that provide these products can help businesses threatened by others' unscrupulous actions.